RESUMO
The experience of the application of 78 patients after various laparoscopic procedures was generalized. As perioperative anesthesia drug Infulgan (production of corporation "Jury-Farm") was applyed. Appointment of Infulgan in standard dose ensured the achievement expressed analgesic effect, reducing the volume of injected opioids and frequency of adverse reactions.
Assuntos
Acetaminofen/uso terapêutico , Analgésicos não Narcóticos/uso terapêutico , Antipiréticos/uso terapêutico , Laparoscopia/métodos , Dor/prevenção & controle , Acetaminofen/farmacocinética , Adulto , Analgésicos não Narcóticos/farmacocinética , Analgésicos Opioides/uso terapêutico , Antipiréticos/farmacocinética , Apendicectomia , Criança , Colecistectomia Laparoscópica , Hepatectomia , Humanos , Histerectomia , Ovariectomia , Dor/fisiopatologiaRESUMO
Experience of application of combined preparation Ciprolet A (ciprofloxacine 500 mg, tinidazol 600 mg) in 27 patients after performed reconstructive operations for surgical diseases of abdominal organs as well as in 50 patients in destructive forms of an acute cholecystitis was summarized. Possibility of the preparation application in ambulatory conditions constitutes its advantage.
Assuntos
Antibacterianos/uso terapêutico , Ciprofloxacina/uso terapêutico , Procedimentos Cirúrgicos do Sistema Digestório/efeitos adversos , Infecções Intra-Abdominais/tratamento farmacológico , Tinidazol/uso terapêutico , Antibacterianos/administração & dosagem , Ciprofloxacina/administração & dosagem , Combinação de Medicamentos , Humanos , Infecções Intra-Abdominais/etiologia , Infecções Intra-Abdominais/microbiologia , Infecções Intra-Abdominais/prevenção & controle , Tinidazol/administração & dosagemRESUMO
The results of application of the antibacterial chinolone preparation maxicine in hepatobiliary surgery and gynecology in 28 patients were analyzed. In 6 patients the preparation was applied after reconstructive operations on biliary tructs (high hepaticojejunostomy for cicatricial stricture of biliary ducts), in 22--after laparoscopic operations (cholecystectomy, choledocholithotomy, excision of suppurated ovarian cysts). The spectrum of causative agents was presented. There was proved a high efficacy of the preparation for prophylaxis and treatment of the diseases and postoperative complications after interventions on the hepatobiliary zone organs and the ovarian cystic affection.
Assuntos
Antibacterianos/uso terapêutico , Procedimentos Cirúrgicos do Sistema Biliar/métodos , Procedimentos Cirúrgicos em Ginecologia/métodos , Hepatectomia/métodos , Infecção da Ferida Cirúrgica , Antibacterianos/administração & dosagem , Compostos Aza/administração & dosagem , Compostos Aza/uso terapêutico , Feminino , Fluoroquinolonas , Humanos , Moxifloxacina , Quinolinas/administração & dosagem , Quinolinas/uso terapêutico , Infecção da Ferida Cirúrgica/tratamento farmacológico , Infecção da Ferida Cirúrgica/microbiologia , Infecção da Ferida Cirúrgica/prevenção & controle , Resultado do TratamentoRESUMO
The experience of drug use in the clinic Enerliv (of "Berlin - Chemie Menarini" Germany) in 58 patients is the complex treatment of postcholecystectomy syndrome in generalised. The drug has hepatoprotective and cholesterol-lowering effect, effectively eliminates pain and dyspeptic symptoms, normalize biochemical parameters.
Assuntos
Colecistectomia/efeitos adversos , Fosfolipídeos/uso terapêutico , Síndrome Pós-Colecistectomia/tratamento farmacológico , Anticolesterolemiantes/uso terapêutico , Humanos , Fosfatidilcolinas/uso terapêutico , Síndrome Pós-Colecistectomia/etiologiaRESUMO
The experience of the drug Ornigil (infusion form ornidazole) production of "Yuria-Pharm" (Ukraine) in the treatment of the hepatopancreatobiliary zone organs diseases (acute destructive cholecystitis, pancreatitis, cholangitis, liver abscess), as well as for the prevention of purulent--septic complications after surgery for about these diseases.
Assuntos
Cavidade Abdominal/cirurgia , Antibacterianos/uso terapêutico , Ornidazol/uso terapêutico , Assistência Perioperatória/métodos , Complicações Pós-Operatórias/prevenção & controle , Sepse/prevenção & controle , Antibacterianos/administração & dosagem , Bactérias Anaeróbias/efeitos dos fármacos , Doenças do Sistema Digestório/cirurgia , Quimioterapia Combinada , Humanos , Infusões Intravenosas , Ornidazol/administração & dosagem , Complicações Pós-Operatórias/microbiologia , Sepse/microbiologia , Resultado do TratamentoRESUMO
Experience of treatment of 105 patients, operated for the abdominal organs diseases, owing various degree of risk of an acute postoperative pancreatitis (APOP) occurrence, was summarized. Octrestatin was injected perioperatively in patients of the main group, in a control group it was not applied. Complex pancreatoprotective therapy was conducted in patients of both groups. In prophylactic application of octrestatin the trustworthy APOP occurrence frequency reduction was noted.
